JP2024515577A5 - - Google Patents
Info
- Publication number
- JP2024515577A5 JP2024515577A5 JP2023562188A JP2023562188A JP2024515577A5 JP 2024515577 A5 JP2024515577 A5 JP 2024515577A5 JP 2023562188 A JP2023562188 A JP 2023562188A JP 2023562188 A JP2023562188 A JP 2023562188A JP 2024515577 A5 JP2024515577 A5 JP 2024515577A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor
- variant
- binding site
- csfr
- csf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163171933P | 2021-04-07 | 2021-04-07 | |
| US202163172025P | 2021-04-07 | 2021-04-07 | |
| US202163171950P | 2021-04-07 | 2021-04-07 | |
| US202163171980P | 2021-04-07 | 2021-04-07 | |
| US63/172,025 | 2021-04-07 | ||
| US63/171,980 | 2021-04-07 | ||
| US63/171,950 | 2021-04-07 | ||
| US63/171,933 | 2021-04-07 | ||
| PCT/CA2022/050540 WO2022213208A1 (en) | 2021-04-07 | 2022-04-07 | Modified granulocyte colony-stimulating factor (g-csf) and chimeric cytokine receptors binding same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515577A JP2024515577A (ja) | 2024-04-10 |
| JP2024515577A5 true JP2024515577A5 (https=) | 2025-04-15 |
Family
ID=83544985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023562188A Pending JP2024515577A (ja) | 2021-04-07 | 2022-04-07 | 修飾された顆粒球コロニー刺激因子(g-csf)及びこれに結合するキメラサイトカイン受容体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240254182A1 (https=) |
| EP (1) | EP4320168A4 (https=) |
| JP (1) | JP2024515577A (https=) |
| KR (1) | KR20240004453A (https=) |
| AU (1) | AU2022254143A1 (https=) |
| CA (1) | CA3213795A1 (https=) |
| IL (1) | IL307272A (https=) |
| MX (1) | MX2023011880A (https=) |
| WO (1) | WO2022213208A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250057883A1 (en) * | 2021-12-23 | 2025-02-20 | The Trustees Of The University Of Pennsylvania | Controllable stimulation of genetically engineered lymphocytes for the treatment of cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08511000A (ja) * | 1993-04-06 | 1996-11-19 | フレッド ハッチンソン キャンサー リサーチ センター | リンパ球におけるキメラサイトカインレセプター |
| BRPI0918553A2 (pt) * | 2008-09-19 | 2016-03-08 | Maxygen Inc | método para tratar ou previnir neutropenia em um paciente submetido à exposição à radiação, e, uso de uma variante de fator de estimulação de colônia de granulócito. |
| CN117659160A (zh) * | 2015-09-11 | 2024-03-08 | 小利兰·斯坦福大学托管委员会 | 生物相关正交细胞因子/受体对 |
| US20200397821A1 (en) * | 2017-03-03 | 2020-12-24 | Exuma Biotech Corp | Methods and compositions for transducing and expanding lymphocytes and regulating the activity thereof |
| CN111819192A (zh) * | 2018-03-02 | 2020-10-23 | 艾洛基治疗公司 | 可诱导的嵌合细胞激素受体 |
| EP4041893A4 (en) * | 2019-10-08 | 2023-08-30 | Provincial Health Services Authority | CHEMERACY CYTOKINE RECEPTORS |
| EP4041760A4 (en) * | 2019-10-08 | 2023-10-11 | Zymeworks BC Inc. | Modified extracellular domain of granulocyte colony-stimulating factor receptor (g-csfr) and cytokines binding same |
-
2022
- 2022-04-07 AU AU2022254143A patent/AU2022254143A1/en not_active Abandoned
- 2022-04-07 US US18/286,045 patent/US20240254182A1/en active Pending
- 2022-04-07 MX MX2023011880A patent/MX2023011880A/es unknown
- 2022-04-07 CA CA3213795A patent/CA3213795A1/en active Pending
- 2022-04-07 EP EP22783744.0A patent/EP4320168A4/en active Pending
- 2022-04-07 KR KR1020237038003A patent/KR20240004453A/ko active Pending
- 2022-04-07 WO PCT/CA2022/050540 patent/WO2022213208A1/en not_active Ceased
- 2022-04-07 IL IL307272A patent/IL307272A/en unknown
- 2022-04-07 JP JP2023562188A patent/JP2024515577A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Morris et al. | The molecular details of cytokine signaling via the JAK/STAT pathway | |
| Cameron et al. | Cytokines, chemokines and their receptors | |
| Hyun Kim et al. | Functional reconstitution and regulation of IL-18 activity by the IL-18Rβ chain | |
| Morán et al. | Cytokines, chemokines and growth factors | |
| Oppenheim | Cytokines: past, present, and future | |
| Thomson et al. | The cytokine handbook, two-volume set | |
| Parrish-Novak et al. | Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses | |
| Garbers et al. | Plasticity and cross-talk of interleukin 6-type cytokines | |
| Akira | The role of IL-18 in innate immunity | |
| Dinarello | Historical insights into cytokines | |
| Heim | The Jak–STAT pathway: specific signal transduction from the cell membrane to the nucleus | |
| Kunkel et al. | The role of chemokines in inflammatory joint disease | |
| Kitaya et al. | Spatial and temporal expression of ligands for CXCR3 and CXCR4 in human endometrium | |
| Cameron et al. | Cytokines and chemokines—their receptors and their genes: an overview | |
| JP2022552949A5 (https=) | ||
| Borchers et al. | In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration | |
| CA2390690C (en) | Tethered ligands and methods of use | |
| Sahoo et al. | Interleukin and interleukin receptor diversity: role of alternative splicing | |
| Gracie | Interleukin-18 as a potential target in inflammatory arthritis | |
| JP2024515577A5 (https=) | ||
| Foster et al. | Cytokine–receptor pairing: accelerating discovery of cytokine function | |
| Thorburn et al. | CXC and CC chemokines induced in human renal epithelial cells by inflammatory cytokines | |
| Hawley et al. | Growth control mechanisms in multiple myeloma | |
| Pietrzak et al. | Genes and structure of selected cytokines involved in pathogenesis of psoriasis. | |
| Nakajima et al. | Soluble interleukin‐6 receptor is released from receptor‐bearing cell lines in vitro |